In silico screening for non-nucleoside HIV-1 reverse transcriptase inhibitors using physicochemical filters and high-throughput docking followed by in vitro evaluation.
Bustanji Y, Al-Masri IM, Qasem A, Al-Bakri AG, Taha MO, Chem Biol Drug Des, 2009 Sep - link

Docking simulations and in vitro assay unveil potent inhibitory action of papaverine against protein tyrosine phosphatase 1B.
Bustanji Y, Taha MO, Al-Masri IM, Mohammad MK, Biol Pharm Bull, 2009 Apr - link

Homology modeling of MCH1 receptor and validation by docking/scoring and protein-aligned CoMFA.
Abu-Hammad A, Zalloum WA, Zalloum H, Abu-Sheikha G, Taha MO, Eur J Med Chem, 2009 Jun - link

Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.
Bustanji Y, Taha MO, Almasri IM, Al-Ghussein MA, Mohammad MK, Alkhatib HS, J Enzyme Inhib Med Chem, 2008 Aug 7 - link

Olanzapine inhibits glycogen synthase kinase-3beta: an investigation by docking simulation and experimental validation.
Mohammad MK, Al-Masri IM, Taha MO, Al-Ghussein MA, Alkhatib HS, Najjar S, Bustanji Y, Eur J Pharmacol, 2008 Apr 14 - link

Combining docking, scoring and molecular field analyses to probe influenza neuraminidase-ligand interactions.
Abu Hammad AM, Afifi FU, Taha MO, J Mol Graph Model, 2007 Sep - link

Berberine potently inhibits protein tyrosine phosphatase 1B: investigation by docking simulation and experimental validation.
Bustanji Y, Taha MO, Yousef AM, Al-Bakri AG, J Enzyme Inhib Med Chem, 2006 Apr - link

Effects of variable docking conditions and scoring functions on corresponding protein-aligned comparative molecular field analysis models constructed from diverse human protein tyrosine phosphatase 1B inhibitors.
Taha MO, AlDamen MA, J Med Chem, 2005 Dec 15 - link